Filter by:
First Kidney Transplant From A Genetically Modif...
At the outset of RMS LifeRisks longevity modeling in 2007, one potential advance (vitagion) identified on the medical horizon was…
Building a New Frontier in Pandemic Risk Modelin...
Since 2020 and the start of the COVID-19 pandemic, we have all been acutely aware of the wide-ranging impact that pandemics can have in terms…
2023 Nobel Prize in Physiology or Medicine Award...
A benchmark for modeling progress in the field of human longevity is the Nobel Prize in Physiology or Medicine, which has been awarded…
World Malaria Day: First National Approval of Ga...
During the roll-out of the COVID-19 vaccines, more developed countries were able to negotiate priority access, while developing countries,…
Living To 100: Society of Actuaries Symposium 2023
The triennial Society of Actuaries ‘Living to 100 Symposium’ was held in Orlando, Florida, (January 16-18, 2023), a unique conference that…
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…